no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy
|
de Jong, J.C |
|
2001 |
19 |
31 |
p. 4452-4464 13 p. |
article |
2 |
Antineoplastic therapy in children and adolescents – a retrospective analysis
|
Arya, Subhash C. |
|
2001 |
19 |
31 |
p. 4357- 1 p. |
article |
3 |
A purified inactivated Japanese encephalitis virus vaccine made in vero cells
|
Srivastava, Ashok K. |
|
2001 |
19 |
31 |
p. 4557-4565 9 p. |
article |
4 |
A randomised comparison of two inactivated hepatitis A vaccines, Avaxim™ and Vaqta™, given as a booster to subjects primed with Avaxim™
|
Clarke, Paul |
|
2001 |
19 |
31 |
p. 4429-4433 5 p. |
article |
5 |
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66
|
Rosas, J.E. |
|
2001 |
19 |
31 |
p. 4445-4451 7 p. |
article |
6 |
DNA vaccination against v-src oncogene-induced tumours in congenic chickens
|
Plachý, Jiřı́ |
|
2001 |
19 |
31 |
p. 4526-4535 10 p. |
article |
7 |
Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection
|
Van Reeth, Kristien |
|
2001 |
19 |
31 |
p. 4479-4486 8 p. |
article |
8 |
Endemic infection of a cat colony with a feline calicivirus closely related to an isolate used in live attenuated vaccines
|
Radford, Alan D. |
|
2001 |
19 |
31 |
p. 4358-4362 5 p. |
article |
9 |
Features of the antibody response attributable to plasmid backbone adjuvanticity after DNA immunization
|
Hervé, Maxime |
|
2001 |
19 |
31 |
p. 4549-4556 8 p. |
article |
10 |
First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease
|
Torres, Juan M |
|
2001 |
19 |
31 |
p. 4536-4543 8 p. |
article |
11 |
FMD in the UK—the 2001 outbreak; what if...?
|
Spier, R.E. |
|
2001 |
19 |
31 |
p. 4339-4341 3 p. |
article |
12 |
From genome to vaccine: in silico predictions, ex vivo verification
|
De Groot, Anne S. |
|
2001 |
19 |
31 |
p. 4385-4395 11 p. |
article |
13 |
High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates
|
Shokri, F |
|
2001 |
19 |
31 |
p. 4544-4548 5 p. |
article |
14 |
IgG antibody subclass responses determined by immunoblot in infants’ sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine
|
Martin, Sarah |
|
2001 |
19 |
31 |
p. 4404-4408 5 p. |
article |
15 |
Immunogenicity and efficacy of one dose measles–mumps–rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age
|
Ceyhan, Mehmet |
|
2001 |
19 |
31 |
p. 4473-4478 6 p. |
article |
16 |
Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine
|
Knutsson, Nina |
|
2001 |
19 |
31 |
p. 4396-4403 8 p. |
article |
17 |
Live attenuated influenza virus vaccines: new options for the prevention of influenza
|
Nichol, Kristin L. |
|
2001 |
19 |
31 |
p. 4373-4377 5 p. |
article |
18 |
Meeting Announcement
|
|
|
2001 |
19 |
31 |
p. 4576- 1 p. |
article |
19 |
Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6–8 October, 2000
|
Cartwright, Keith |
|
2001 |
19 |
31 |
p. 4347-4356 10 p. |
article |
20 |
Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery
|
Oh, Yu-Kyoung |
|
2001 |
19 |
31 |
p. 4519-4525 7 p. |
article |
21 |
Passive transfer of protection against Bacillus anthracis infection in a murine model
|
Beedham, R.J. |
|
2001 |
19 |
31 |
p. 4409-4416 8 p. |
article |
22 |
Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity
|
Curtidor, H |
|
2001 |
19 |
31 |
p. 4496-4504 9 p. |
article |
23 |
Plasmodium falciparum circumsporozoite (CS) protein peptides specifically bind to HepG2 cells
|
Suarez, Jorge E. |
|
2001 |
19 |
31 |
p. 4487-4495 9 p. |
article |
24 |
Potential of Klebsiella pneumoniae cytotoxin toxoid as vaccine against klebsiellosis in rabbits and mice
|
Singh, B.R |
|
2001 |
19 |
31 |
p. 4505-4510 6 p. |
article |
25 |
Progress towards global polio eradication
|
Hull, Harry F. |
|
2001 |
19 |
31 |
p. 4378-4384 7 p. |
article |
26 |
Protection against influenza virus challenge by topical application of influenza DNA vaccine
|
Watabe, Setsuko |
|
2001 |
19 |
31 |
p. 4434-4444 11 p. |
article |
27 |
Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination
|
Orciari, Lillian A. |
|
2001 |
19 |
31 |
p. 4511-4518 8 p. |
article |
28 |
Report on The Third Annual Walker's Cay Colloquium on Cancer Vaccines
|
Goldstein, Allan L. |
|
2001 |
19 |
31 |
p. 4342-4346 5 p. |
article |
29 |
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis
|
Fulop, Mark |
|
2001 |
19 |
31 |
p. 4465-4472 8 p. |
article |
30 |
Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States
|
Lingappa, Jairam R. |
|
2001 |
19 |
31 |
p. 4566-4575 10 p. |
article |
31 |
The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep
|
Drew, Damien R. |
|
2001 |
19 |
31 |
p. 4417-4428 12 p. |
article |
32 |
THIRD WORLD CONGRESS ON VACCINES AND IMMUNISATION
|
|
|
2001 |
19 |
31 |
p. 4577- 1 p. |
article |
33 |
Towards the rational design of Th1 adjuvants
|
Moingeon, P. |
|
2001 |
19 |
31 |
p. 4363-4372 10 p. |
article |